(CMPX) Compass Therapeutics - Performance 12.7% in 12m
Compare CMPX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-41.49%
#61 in Group
Rel. Strength
67.81%
#2562 in Universe
Total Return 12m
12.66%
#41 in Group
Total Return 5y
-79.06%
#88 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -20.61%
(?) Percentile in Group
12m Total Return: CMPX (12.7%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CMPX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CMPX
| Total Return (including Dividends) | CMPX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.95% | 11.81% | 13.81% |
| 3 Months | -54.36% | -13.61% | -6.30% |
| 12 Months | 12.66% | -12.29% | 10.65% |
| 5 Years | -79.06% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | CMPX | XBI | S&P 500 |
| 1 Month | 37.6% | 72.9% | 83% |
| 3 Months | -87.3% | -83% | -75.3% |
| 12 Months | 70.9% | -51.6% | 50.1% |
| 5 Years | -60.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #74 | 0.13% | -1.64% |
| 3 Month | #166 | -47.2% | -51.3% |
| 12 Month | #41 | 28.5% | 1.82% |
| 5 Years | #77 | -62.9% | -85.8% |
FAQs
Does CMPX Compass Therapeutics outperforms the market?
Yes,
over the last 12 months CMPX made 12.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months CMPX made -54.36%, while XBI made -13.61%.
Over the last 3 months CMPX made -54.36%, while XBI made -13.61%.
Performance Comparison CMPX vs Indeces and Sectors
CMPX vs. Indices CMPX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.38% | -1.86% | 3.83% | 2.01% |
| US NASDAQ 100 | QQQ | -3.57% | -5.41% | 3.62% | 1.02% |
| US Dow Jones Industrial 30 | DIA | -3.79% | 1.96% | 4.12% | 4.95% |
| German DAX 40 | DAX | -3.36% | -3.01% | -22.4% | -13.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.56% | 0.12% | 3.06% | 5.29% |
| Hongkong Hang Seng | HSI | -6.55% | -7.98% | -4.53% | -1.02% |
| India NIFTY 50 | INDA | 1.54% | 7.11% | 3.39% | 12.9% |
| Brasil Bovespa | EWZ | -4.43% | -5.29% | -4.87% | 21.0% |
CMPX vs. Sectors CMPX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.02% | -1.46% | -3.23% | -8.90% |
| Consumer Discretionary | XLY | -3.76% | -2.28% | 4.81% | -1.61% |
| Consumer Staples | XLP | -2.52% | 5.36% | -3.10% | 3.54% |
| Energy | XLE | -3.20% | 5.19% | 10.4% | 22.1% |
| Financial | XLF | -4.48% | -1.57% | -3.27% | -9.77% |
| Health Care | XLV | -0.37% | 11.1% | 8.82% | 16.7% |
| Industrial | XLI | -5.07% | -4.87% | 2.40% | 1.67% |
| Materials | XLB | -3.18% | -1.61% | 8.72% | 17.9% |
| Real Estate | XLRE | -2.06% | 0.41% | 3.08% | -2.79% |
| Technology | XLK | -4.46% | -9.27% | 6.71% | 5.56% |
| Utilities | XLU | -3.43% | 2.36% | -3.83% | -4.81% |
| Aerospace & Defense | XAR | -5.36% | -9.21% | -7.67% | -14.7% |
| Biotech | XBI | 3.21% | 0.14% | 24.0% | 25.0% |
| Homebuilder | XHB | -3.85% | 0.47% | 17.0% | 20.2% |
| Retail | XRT | -5.28% | -2.70% | 8.07% | 14.1% |